Belluscura shares soar after announcing ‘groundbreaking’ license and royalty agreement

Belluscura shares soared in early trade on Wednesday after the medical device developer said they had entered into a ‘groundbreaking’ license and royalty agreement with Chinese partner InnoMax.

The agreement will provide InnoMax with exclusive rights to distribute Belluscura’s portable oxygen concentrator devices in China, Hong Kong, Macau and Singapore and is subject to a minimum of $55m in royalties over the life of the agreement.

Belluscura shares were 21% higher at 50p at the time of writing on Wednesday.

“I am very excited to build and strengthen our relationship with InnoMax,” said Bob Rauker, Chief Executive Officer, Belluscura.

“An estimated 100 million people suffer from COPD in China alone, approximately six times the number of patients in the US, demonstrating the need for oxygen therapy in China and associated Territories. This agreement provides the basis for an extremely financially beneficial partnership for both companies as we jointly broaden the reach of Belluscura’s next-generation technology.”

The agreement runs for a total of 10 years with the option for both parties to mutually agree for the agreement to become non-exclusive after 5 years.

There are minimum royalties attached to the agreement including $27.5m if the license is converted to non-exclusive from year 6 and up to $55m in royalties if the license remains exclusive for the entire term.

After announcing orders for 6,500 units earlier this month for around $15m, today’s announcement is another landmark development for Belluscura which now has clear revenue generation visibility over multiple years.

FTSE 100 surges after China acts to boost equity market, interest rate fears subside

The FTSE 100 surged on Tuesday in the first trading session after the Bank Holiday as the index played catch-up with a strong session for global equities yesterday.

China moved to support their domestic equity market by cutting levies on trading over the weekend, which resulted in a sharp jump in Chinese stocks that rippled through global equities on Monday.

In addition, the absence of any negative fallout from the Jackson Hole Symposium helped boost sentiment and US and European equities gained even as the Chinese stock market rally faded.

The FTSE 100 was 1.4% higher at the time of writing on Tuesday.

“The market may have been underwhelmed by China’s initial efforts to restore confidence, but that doesn’t seem to be the case with the latest measures, which have given Chinese and global stocks a real boost,” said AJ Bell investment director Russ Mould.

“Whether the medicine Beijing is doling out will deal with the causes rather than just the symptoms of its economic challenges is debatable, but for the time being it is at least doing enough to restore sentiment.

“The lack of any big shocks in US Federal Reserve chair Jerome Powell’s Jackson Hole speech also seems to have helped create the conditions for a late summer rally.”

FTSE 100 movers

The FTSE 100 gains were broad on Tuesday, with 98 of the 100 constituents in positive territory shortly after 2pm.

Persimmon was the top riser, gaining 4% after the Department for Levelling Up, Housing & Communities said they would ease water pollution regulations that would help push through the construction of an additional 100,000 homes.

Taylor Wimpey and Barratt Developments joined the action with gains of 2.7% and 3.8%, respectively.

Bunzl was among the gainers after their revenue edged higher and margins increased despite ongoing inflationary pressures.

Positive sounds from China helped Prudential higher with an increase of 3.8%.

Lloyds shares are building a base for a leg higher

The Lloyds share price has undergone a period of consolidation, and the charts suggest the FTSE 100 bank has built a base for a leg higher.

Lloyds are navigating a challenging economic environment. On the one hand, they are enjoying the benefits of higher interest rates on net interest margins while, on the other hand, we are starting to see housing activity slow.

Higher interest rates are proving to be a double-edged sword for Lloyds after reaping the rewards in the first half and subsequently feeling the wrath of the FCA for not passing these on to their customers.

As we move firmly into the second half and approach the 4th quarter, the question remains whether Lloyds have squeezed all they can from the current cycle. This question has led to a period of consolidation in the 42-43p region – a key level of support.

“Much will be made of Lloyds Banking Group’s 23% jump in first-half profit amid the backdrop of a cost-of-living crisis and increased pressure from regulators to share the benefits of interest rate hikes with savers,” commented Danni Hewson, head of financial analysis at AJ Bell after Lloyds reported last month.

“The net interest margin, the difference between what a bank earns in interest from loans and what it pays out, is slightly higher than analysts had forecast for the quarter, though down on where it had been in the three months previously.

“There are storm clouds gathering as the country’s biggest mortgage lender has to consider how many of its customers are likely to struggle as they face a jump from ultra-low fixed rates to the unexpected ‘new normal’.

“Lloyds boss Charlie Nunn admitted that customers were facing “significant challenges” and said that over 200,000 of its mortgage customers were among those worst affected by rising costs, a number that’s likely to be dwarfed over the coming months. To that end the bank has set aside an extra £662 million to cover expected ‘bad’ loan losses.

“For investors the bank delivered a mottled picture, with financial performance expected to slow and despite a sweetener for shareholders with a 15% jump on last year’s dividend pay-out the uncertainty has been enough to prompt a sell-off this morning.”

The clouds Hewson alludes to look now priced in, and the Lloyds share price looks set for a move to the upside. The 5.7% yield is extremely attractive and will compensate investors for any wait for capital growth.

Lloyds trades at 5.4x earnings and at just 0.6x book value. Value investors will appreciate these metrics.

A move higher could be derailed by a material deterioration in the UK economy, but we have no evidence this will occur in the immediate future. The second half will be softer than the first, and investors have quickly baked this into Lloyd’s cake.

If optimism prevails, 50p could be on the cards.

London’s AIM: Five reasons why we are near maximum despondency (and maximum financial opportunity)

The point of maximum despondency in any financial market cycle is the point at which investors and traders have the maximum financial opportunity. However, many fail to take advantage of this opportunity due to despondency with their investments.

It is now clear the euphoric conditions during the pandemic were the worst time to invest in the broad FTSE AIM All-Share that peaked above 1,300 in late 2021.

Fast forward two years, the index has nearly halved, and the AIM has more or less completed the down leg of market emotions. We outline five reasons why AIM is near the point of maximum financial opportunity.

Interest rates have nearly peaked

The Bank of England hiking cycle has killed AIM. The natural revaluation of equity due to a higher risk-free rate has dented valuations, and this is particularly felt at the small cap end of the market.

Predicting the Bank of England’s next move has proved a fool’s errand, with the Monetary Policy Committee consistently surprising markets with rate decisions. Nevertheless, there is an abundance of evidence suggesting we are near the end of the hiking cycle.

While the BoE may hike again this year, markets are pricing only one or two more rate hikes before a period of plateauing rates.

This period of steady rates will provide the opportunity for investors to regain their confidence and reassess their finances. Such a period favours high-growth opportunities, and the eventual rate cut could provide a catalyst for significant inflows into small cap shares.

Consumer confidence is improving

Day-to-day liquidity in London’s AIM is driven predominately by UK-based private investors.

The propensity of these private investors to invest their savings in high-risk/high-reward opportunities is highly cyclical, and their perceptions of the economic landscape and general mood have as much of an impact on London’s AIM as the underlying fundamentals of constituent companies. 

One of the biggest predictors of London’s AIM has long been UK consumer confidence, and GfK’s monthly reading has a strong correlation with AIM’s performance.

GfK’s consumer confidence reading has traditionally been an early predictor of a turn in London’s AIM. Each significant move in AIM since 2007 has been preceded by a shift in GfK Consumer Confidence, although there is a variable lag in AIM’s performance.

In the 2008 financial crisis, consumer confidence fell in line with AIM but since then, a turn in GfK’s reading has preceded a turn in the AIM by periods ranging from a month to a couple of years.

Consumer confidence has been gradually improving since October last year, while AIM has continued to decline. If history is anything to go by, one would expect a rally in AIM before long.

IPOs have dried up

Capital markets activity is dead. There has been a dearth of AIM IPOs this year as companies push back listings to await more favourable conditions.

Historically, capital markets activity peaks near market tops and a trough in activity occurs near the bottom of the market cycle. It is difficult to imagine capital markets activity getting any worse, and the aforementioned considerations around consumer confidence and interest rates may well spur companies to push ahead with listing.

The relationship between new issues and market emotions is highly correlated, although one would hesitate to claim one causes the other.

Nonetheless, when companies start floating their shares on AIM again, it will lift the mood and mark another step forward after a period of depressed activity.

Good news is being taken badly

There are countless examples of AIM companies issuing good news only for their shares to be met by selling. The market is destroying those releasing bad news.

This is representative of the general despondency of market participants and reflects the underlying pessimism among investors.

Of course, exceptionally good news still propels AIM stocks higher, but there are still questions about whether their share prices are reaching their full potential.

This is symptomatic of underlying investor despondency and reinforces the need for many AIM constituents to improve their communication with the market.

67% of AIM constituents are negative year-to-date

The fifth and final reason AIM could be near the point of maximum financial opportunity is the simplistic performance of constituents this year.

Roughly two-thirds of AIM constituents are trading negatively since the beginning of 2023, highlighting the market’s poor performance in general.

Poor performance is by no means a precursor to positive performance. However, statistical mean reversion would suggest individual constituents are due a rally.

For two-thirds of the index to be down on the year is a clear demonstration of investor despondency, and while things could deteriorate further, one would think the worst is behind us.

Important considerations

As we have outlined five reasons why AIM could be approaching the point of maximum financial gain, it is important to balance these arguments with potential risks.

Firstly, interest rates could continue to rise if inflation doesn’t fall materially. This would negate our first two points.

In addition, we haven’t yet had out-and-out capitulation in the AIM. There has been steady selling, but the bottom hasn’t completely fallen out of the market during severe volatility. However, one may argue the extent of the declines since AIM’s 2021 high more than compensates for highly volatile capitulation.

Star Energy’s Croatian geothermal investment

0

Star Energy (LON: STAR) is moving into geothermal project development in Croatia. This is part of the company’s move to refocus from gas to geothermal energy. The acquired business has an experienced team, and the Croatian government is supportive of the sector. The share price slipped 2.33% to 10.9p and it has fallen by one-third so far in 2023.

A 51% interest in A14 Energy is being acquired for €1.3m in cash plus €300,000 back costs. A14 owns the Ernestinovo licence in the Pannonian Basin in Croatia. Bids have been placed for further licences. Up to €1.5m more is payable if the licences are granted.

AIM-quoted Star Energy will fully carry the gross cost of up to €13.2m for up to four wells over the next five years. That is repayable from future cash flows. There is a commitment to re-enter an existing well by April 2024 and that will cost €1.47m.

Croatia has one geothermal power project in operation, with a capacity of 17.5 Mwe, and the local geology is highly prospective. It is estimated that the potential for geothermal energy is more than 1GW.

Star Energy is also seeking projects in the UK. It has an agreement with Cornish Lithium to evaluate sites for geothermal heat in southwest England.

AIM movers: Quadrise reassures investors and Pelatro set to leave AIM

0

Quadrise (LON: QED) says that the failure of the Utah authorities to grant its licensee Valkor a unitisation will not impact the development plan a t the primary project site and the $15m of financing. A drilling permit is anticipated in September. Unitisation could be granted by the first quarter of next year. The Quadrise technology will be used in the production of heavy oil. The share price recovered 24.6% to 1.1025p, but it is still lower than a fortnight ago.

Pantheon Resources (LON: PANR) says an independent expert report confirms gross 2C contingent resources of total marketable liquids of 963mmbbls at the Kodiak project in Alaska – roughly one-third oil and two-thirds natural gas liquids. That is well below the company’s own estimate of 1.7 billion barrels. An assessment of the resource of Alkaid at the Ahpun project should be finished before the end of the year. The share price improved 10.7% to 15.05p. Canaccord Genuity has a NPV10 target price of 100p.

Hutchmed (China) Ltd (LON: HCM) says the Center for Drug Evaluation of China’s National Medical Products Administration has granted breakthrough therapy designation to savolitinib for the treatment of “locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma patients with mesenchymal epithelial transition factor amplification who have failed at least two lines of standard therapies”. This means that the treatment will have priority review when a new drug application is submitted. A phase II study is planned. The share price increased 8.17% to 241.75p.

Medical scanning technology developer Polarean Imaging (LON: POLX) has been granted a new reimbursement code for the Polarean XENOVIEW (xenon Xe 129, hyperpolarised) technology by the US Centers for Medicare & Medicaid Services. The payment level will be announced in a few weeks, and it commences from 1 October. The share price improved 8.2% to 16.5p.

Pre-clinical antibody developer Fusion Antibodies (LON: FARN) has received the first order for its AI/ML-Ab services from Australia. The share price rose 7.41% to 290p.

FALLERS

Pelatro (LON: PTRO) will ask shareholders to vote to cancel the AIM quotation because of the cost and the inability to raise cash. Finance director Nic Hellyer is leaving the board. A matched bargain facility will be put in place. The share price slumped 69.2% to 1p.

Grafenia (LON: GRA) is raising £23m via a placing at 8.5p/share and a further £4.9m can be raised through an open offer. The share price slipped 9.76% to 9.25p. The cash will be used to repurchase bonds and pay consideration for past and future acquisitions to expand in the vertical market software sector. Last year £11.2m of bonds were issued to finance four acquisitions. The focus is businesses where a majority of revenues are recurring and there is a defined market niche. The valuation would be up to seven times adjusted EBITDA.

Volvere (LON: VLE) chief executive Jonathan Lander has died. His brother Nick Lander will take over his responsibilities. Jonathan Lander has a 10.2% shareholding. The share price fell 5.46% to 1125p. Oil and gas company Arrow Exploration (LON: AXL) has more than doubled its second quarter revenues from $5.02m to $10.3m. There was $4.9m of cash generated from operations. There was $10.8m in cash at the end of June 2023. The share price declined 2.86% to 17p.

Pantheon Resources – latest report validates the massive scale of its 1bn barrels Kodiak resource, shares up 15%

Jay Cheatham, the CEO of Pantheon Resources (LON:PANR) sounded very excited about the Netherland Sewell & Associates intensive review of the Lower Basin Floor Fan reservoir of the company’s Kodiak project on the North Slope of Alaska.

“This really is a big deal.

 A credible third-party estimate of nearly one billion barrels of recoverable liquids for a company the size of Pantheon is an incredible achievement, validating our geological model.

This is the first IER conducted on our largest asset and will have enormous value in financing discussions and in attracting potential partners.

As I have repeatedly said, big oilfields continue to get bigger, and with additional wells and data points we expect this contingent resource to grow and for some or all to be classified as reserves once we achieve a Final Investment Decision.”

The report confirms gross (and net) 2C contingent resources of “total marketable liquids” of 963 mmbbls.

The 2C estimates (best estimates) of oil and natural gas liquids total 962.5m barrels of marketable liquids.

The NGLs on Pantheon’s projects are of material value because they can be blended with the oil and the combined stream of oil, condensate and have been estimated by management to yield approximately 90% of the value of the Alaska North Slope price per barrel.

With some 126,000 acres of field, the company believes that this is one of the largest basin floor fan systems discovered onshore in the past few decades. 

Analyst Charlie Sharp at Canaccord Genuity Capital Markets has rated the £141m capitalised group’s shares as a Speculative Buy, setting a 100p Price Target.

We see this figure a “best estimate” of almost 1bn barrels – as an important confirmation of the scale of the Kodiak discovery.

It is a critical first step in the process of further appraisal towards the potential establishment of the commerciality of this very large, now independently verified, resource base and Pantheon’s aim to deliver recognition of the $5-$10/bbl market valuation for those resources.

The groups shares are up 15% this morning, 2p better at 15.64p.

Income investors should not ignore this US bond ETF

US Treasury prices have sunk during the US hiking cycle, and long-dated bonds now offer yields that rival the broad FTSE 100 index.
Bond investment is typically associated with income, but this ETF provides a substantial yield and an opportunity for capital appreciation. 
Longer-dated bonds have higher duration risk, which means changes in the underlying price of the bond are extremely sensitive to interest rate changes. While this is a risk, it can also be an opportunity.
Investing in this ETF is a play on the US cutting rates while achieving a 4.27% yield. It is also a play on a risk avers...

Aston Martin – shares are on the run upwards, is a bidder in the wings?

Some 19.77m shares of Aston Martin Lagonda Global Holdings (LON:AML) were traded last Friday, with the market abuzz with rumours of an early bid from China.
One assumes that if such a bid actually transpires it would emanate from Geely Holdings, the Chinese automobiles manufacturer that now holds some 16.66% of the luxury car maker’s equity.
Geely, which is controlled by the billionaire Li Shufu, owns Volvo, Polestar, Lotus and the London Electric Vehicle Company amongst several other brands.
The AML shares were traded 5% higher before the weekend, up to 338p, which is still some way below the...

Bunzl shares tick higher as post-pandemic trade normalises

Bunzl has been contending with two key factors driving underlying performance; the pandemic and price inflation. The distribution company enjoyed a jump in activity during the pandemic, which has now diminished and price inflation is flatlining.

These influences were demonstrated in Bunzl’s revenue growing just 0.6% constantly in the six months ending 30th June.

Group adjusted operating profit rose 6.4% to £438.3m while margins expanded slightly to 7.4%.

“Bunzl generates most of its revenue and profit outside the UK, with the US a key region, so it’s not the economic conditions at home that turn the dial. Inflation easing in the US is a double-edged sword. On the one hand, lower input costs have helped margins push higher over the half, but the flip side is a drop in revenue as the pricing on a lot of Bunzl’s products can be linked to inflation,” said Matt Britzman, equity analyst at Hargreaves Lansdown.

“Add in a drop in COVID-related sales, and the underlying business is seeing a bit of weakness creep in, comparable periods are tough though. Aside from lower costs, margins also got a bump from consumers shifting to own-brand products in response to ongoing pressures on income.

Bunzl continues to grow through acquisitions with the company announcing their first investment in Poland today.

“Acquisitions remain key to the Bunzl story, with £350m committed so far this year,” Brizman said.

“Strong cash generation underpins self-funded growth and the 12 acquisitions announced so far this year highlight the intent. The announced acquisition in Poland marks the group’s first foray into the region, one that’s previously been on the radar. The protective equipment distributor fits nicely in with Bunzl’s model and should give a platform to build on in the region.”

Bunzl shares were 3.5% higher at the time of writing.